Methylene Blue: A New Hope for Cancer Treatment?
Apr 19, 2025•10 min
Episode description
Story at-a-glance
- Methylene blue has been shown to shrink tumors and slow cancer growth by targeting cancer cell metabolism and energy production
- Photodynamic therapy with methylene blue uses light activation to destroy cancer cells while leaving healthy cells unharmed, making it a more precise treatment option
- Research on ovarian cancer found that methylene blue forces tumors to shift away from their preferred energy source, making them more vulnerable to treatment
- Unlike chemotherapy, methylene blue treatment does not cause significant side effects or toxicity, making it a promising option for patients with drug-resistant cancers
- Proper dosing is important. Just 5 milligrams of pharmaceutical-grade methylene blue per day is enough to reduce cellular stress and support mitochondrial health
For the best experience, listen in Metacast app for iOS or Android
Open in Metacast